The Negative Role of PDE4 on PTH-induced Signaling in Osteoblasts |
Park, Hyo-Jung
(College of Pharmacy, Sookmyung Women's University)
Noh, A-Long-Sae-Mi (College of Pharmacy, Sookmyung Women's University) Lee, Jung-Min (College of Pharmacy, Sookmyung Women's University) Yim, Mi-Jung (College of Pharmacy, Sookmyung Women's University) |
1 | Xin, W., Tran, T. M., Richter, W., Clark, R. B. and Rich, T. C. : Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling. J. Gen. Physiol. 131, 349 (2008). DOI ScienceOn |
2 | Wakabayashi, S., Tsutsumimoto, T., Kawasaki, S., Kinoshita, T., Horiuchi, H. and Takaoka, K. : Involvement of phosphodiesterase isozymes in osteoblastic differentiation. J. Bone. Miner. Res. 17, 249 (2002). DOI ScienceOn |
3 | Takami, M., Cho, E. S., Lee, S. Y., Kamijo, R. and Yim, M. : Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways. FEBS Lett. 31, 832 (2005). |
4 | Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J. and Boyle, W. J. : Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165 (1998). DOI ScienceOn |
5 | Bruss, M. D., Richter, W., Horner, K., Jin, S. L. and Conti, M. : Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts. J. Biol. Chem. 283, 22430 (2008). DOI ScienceOn |
6 | Kondo, H., Guo, J. and Bringhurst, F. R. : Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. J. Bone. Miner. Res. 17, 1667 (2002). DOI ScienceOn |
7 | Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F. S. 3rd, Frankel, W. N., Lee, S. Y. and Choi, Y. : TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun Nterminal kinase in T cells. J. Biol. Chem. 272, 25190 (1997). DOI ScienceOn |
8 | Datta, N. S. and Abou-Samra A. B. : PTH and PTHrP signaling in osteoblasts. Celllular Signalling 21, 1245 (2009). DOI ScienceOn |
9 | Conti, M. and Beavo, J. : Biochemistry and physiology of cyclic nucleotide phosphodiesterases: Essential components in cyclic nucleotide signaling. Annu. Rev. Biochem. 76, 481 (2007). DOI ScienceOn |
10 | Essayan, D. M. : Cyclic nucleotide phosphodiesterases. J. Allergy Clin. Immunol. 108, 671 (2001). DOI ScienceOn |
11 | Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T. and Martin, T. J. : Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345 (1999). DOI ScienceOn |
12 | Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. and Suda, T. : Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95, 3597 (1998). DOI ScienceOn |
13 | Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J. and Suda, T. : Osteoblastic cells are involved in osteoclast formation. Endocrinology 123, 2600 (1988). DOI ScienceOn |